Resistant herpes simplex virus type 1 infection: An emerging concern after allogeneic stem cell transplantation

Clinical Infectious Diseases

Volumn 31, Issue 4, 2000, Pages 927-935

  Chen, Yolande ^a   Scieux, Catherine ^a   Garrait, Valérie ^a   Socié, Gérard ^a   Rocha, Vanderson ^a   Molina, Jean Michel ^a   Thouvenot, Danielle ^b   Morfin, Florence ^b   Hocqueloux, Laurent ^a   Garderet, Laurent ^a   Espérou, Hélène ^a   Sélimi, Fadhéla ^a   Devergie, Agnès ^a   Leleu, Ghislaine ^a   Aymard, Michèle ^b   Morinet, Frédéric ^a   Gluckman, Eliane ^a   Ribaud, Patricia ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CIDOFOVIR; FOSCARNET;

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; FEMALE; HERPES SIMPLEX VIRUS 1; HUMAN; IN VITRO STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; SCHOOL CHILD; STEM CELL TRANSPLANTATION;

ACYCLOVIR; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CYTOSINE; DRUG RESISTANCE, MICROBIAL; FEMALE; FOSCARNET; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034450742     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/314052     Document Type: Article

References (40)

1. Infections with herpes simplex virus and cell-mediated immunity after marrow transplant
2. Acyclovir prophylaxis of herpes-simplex-virus infections: A randomized, double-blind, controlled trial in bone-marrow-transplant recipients
3. Multicenter collaborative trial of intravenous acyclovir or treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Acyclovir symposium
4. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir
5. Herpes simplex virus infection in cancer patients: Prevention and treatment
6. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from patients receiving multiple courses of treatment with acyclovir
7. Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation
8. Herpes simplex virus resistant to acyclovir: A study in a tertiary care center
9. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients
10. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients
11. Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population
12. Resistance to drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: Risk factors and prognostic significance
13. Clinical manifestations of graft-versus-host disease in human recipients from HLA-matched sibling donors
14. Chronic graft-versus-host disease in man: A long-term clinicopathologic study in 20 Seattle patients
15. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs
16. Mutations in exo III motif of herpes simplex virus DNA polymerase gene can confer altered drug sensitivities
17. HPMPC (cidofovir), PMEA (adefovir), and related nucleoside phosphonate analogues: A review of their pharmacology and clinical potential in the treatment of viral infections
18. Herpes simplex virus resistance to acyclovir
19. Treatment of herpesvirus infections in HIV-infected individuals
20. Herpesvirus infections in persons infected with human immunodeficiency virus
21. Foscarnet-resistant herpes simplex virus infection in patients with AIDS
22. Early foscarnet failure in herpes simplex virus infection in a patient with AIDS
23. Progressive esophagitis from acyclovir-resistant herpes simplex: Clinical roles for DNA polymerase mutants and viral heterogeneity?
24. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT
25. Foscarnet therapy for acyclovir-resistant herpes simplex virus 1 in allogeneic transplant recipients
26. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation
27. Survey of resistance of herpes simplex virus to acyclovir in northwest England
28. Infections in adults undergoing unrelated donor bone marrow transplantation
29. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine (HPMPC)
30. Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir
31. - cytotoxic T lymphocyte responses
32. Tipping the scales of herpes simplex virus reactivation: The important responses are local
33. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models
34. Comparison of immune reconstitution after unrelated and related T-cell depleted bone marrow transplantation: Effect of patient age and donor leucocyte infusions
35. Statistical aspects of prognostic factor studies in oncology
36. Characterization of the DNA polymerase and thymidine kinase genes of herpes simplex virus isolates from AIDS patients in whom acyclovir and foscarnet therapy sequentially failed
37. Treatment with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS
38. Biochemical basis for increased susceptibility to cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity
39. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients
40. Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates